MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Envista Holdings Corporation DPO Ratio 2011-2025 | NVST
Annual DPO Ratio Envista Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.8 | 66.1 | 69.1 | 71 | 92.5 | 61.3 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92.5 | 56.8 | 69.5 |
Quarterly DPO Ratio Envista Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49 | 54.9 | - | 55.4 | 51.7 | 60.5 | - | 58.8 | 58.5 | 71.6 | - | 32.5 | 29.9 | 65 | - | 69.2 | 57.5 | 73.1 | - | 83.6 | 101 | 75.2 | - | 64.9 | 59.6 | 65.4 | - | 33.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 | 29.9 | 60.5 |
DPO Ratio of other stocks in the Medical instruments industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
130 | $ 24.39 | - | $ 1.12 B |  USA |
 |
Baxter International
BAX
|
50.7 | $ 19.68 | 2.77 % | $ 10 B | USA |
 |
Becton, Dickinson and Company
BDX
|
59.3 | $ 200.26 | -0.34 % | $ 57.6 B | USA |
 |
Luminex Corporation
LMNX
|
45.3 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
218 | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
73.7 | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
93.7 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
26.4 | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
3.31 | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
61.4 | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
47.4 | $ 0.71 | -3.6 % | $ 30.1 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
39.5 | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
34.9 | $ 147.79 | -0.43 % | $ 3.6 B | USA |
 |
Alcon
ALC
|
63.6 | $ 79.23 | 0.53 % | $ 40.4 B |  Schweiz |
 |
iRhythm Technologies
IRTC
|
12.6 | $ 171.52 | 1.59 % | $ 5.35 B | USA |
 |
AtriCure
ATRC
|
81.2 | $ 41.41 | -2.29 % | $ 1.94 B | USA |
 |
Atrion Corporation
ATRI
|
31.9 | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
279 | $ 4.8 | 1.05 % | $ 26.5 K | USA |
 |
Repro Med Systems
KRMD
|
52 | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
96.2 | $ 13.38 | 1.83 % | $ 547 M | USA |
 |
The Cooper Companies
COO
|
72.6 | $ 81.12 | -1.17 % | $ 16.2 B | USA |
 |
LeMaitre Vascular
LMAT
|
14.5 | $ 83.58 | -0.5 % | $ 1.88 B | USA |
 |
Glaukos Corporation
GKOS
|
67.2 | $ 111.86 | 2.72 % | $ 5.42 B | USA |
 |
Haemonetics Corporation
HAE
|
41.9 | $ 78.81 | -5.6 % | $ 3.97 B | USA |
 |
InfuSystem Holdings
INFU
|
62.5 | $ 9.18 | -0.65 % | $ 190 M | USA |
 |
Masimo Corporation
MASI
|
84.4 | $ 136.6 | -1.25 % | $ 7.28 B | USA |
 |
Isoray
ISR
|
58.4 | - | 0.03 % | $ 108 M | USA |
 |
Merit Medical Systems
MMSI
|
34.4 | $ 85.98 | -0.83 % | $ 5.01 B | USA |
 |
Intuitive Surgical
ISRG
|
25.7 | $ 554.57 | 2.26 % | $ 197 B | USA |
 |
OraSure Technologies
OSUR
|
36.6 | $ 2.48 | -0.25 % | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
52.9 | $ 2.25 | -6.64 % | $ 22.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
36.5 | $ 0.37 | -5.12 % | $ 29.5 M | USA |
 |
Nephros
NEPH
|
50.5 | $ 4.96 | -1.29 % | $ 51.5 M | USA |
 |
NeuroMetrix
NURO
|
78.1 | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
34.9 | $ 252.48 | 0.05 % | $ 36.9 B | USA |
 |
Pro-Dex
PDEX
|
35.4 | $ 42.14 | -2.86 % | $ 139 M | USA |
 |
STAAR Surgical Company
STAA
|
74.3 | $ 23.59 | -2.24 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
31.8 | $ 252.72 | 0.32 % | $ 24.9 B | USA |
 |
Stereotaxis
STXS
|
99 | $ 2.36 | -0.42 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
68.4 | $ 14.04 | -1.44 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
547 | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
24.3 | $ 158.66 | 0.81 % | $ 8.84 M | USA |
 |
Utah Medical Products
UTMD
|
18 | $ 58.21 | 0.19 % | $ 211 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
54.3 | $ 11.38 | -1.69 % | $ 2.31 B | USA |
 |
Retractable Technologies
RVP
|
48.6 | $ 0.84 | 2.04 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
37.1 | $ 126.36 | -0.24 % | $ 5.92 B | USA |
 |
West Pharmaceutical Services
WST
|
46.4 | $ 270.21 | 0.99 % | $ 19.7 B | USA |